Trial Profile
A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of a 12 Week Treatment of Acute Diverticulitis With Asacol® 2.4 g/Day (400 mg Mesalamine Tablet), Followed by a 9 Month Treatment-free Observation Period
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Diverticulitis
- Focus Proof of concept; Therapeutic Use
- Acronyms DIVA